NASDAQ:CASM - CAS Medical Systems Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 04/18/2019)
Today's Range
Now: $2.45
50-Day Range
MA: $2.45
52-Week Range
Now: $2.45
Volume64,728 shs
Average Volume79,750 shs
Market Capitalization$71.88 million
P/E RatioN/A
Dividend YieldN/A
CAS Medical Systems, Inc, a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolNASDAQ:CASM



Sales & Book Value

Annual Sales$21.92 million
Book Value($0.56) per share


Net Income$-5,960,000.00


Market Cap$71.88 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CASM News and Ratings via Email

Sign-up to receive the latest news and ratings for CASM and its competitors with MarketBeat's FREE daily newsletter.

CAS Medical Systems (NASDAQ:CASM) Frequently Asked Questions

What is CAS Medical Systems' stock symbol?

CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."

How were CAS Medical Systems' earnings last quarter?

CAS Medical Systems Inc (NASDAQ:CASM) released its earnings results on Wednesday, October, 31st. The medical technology company reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical technology company had revenue of $5.38 million for the quarter, compared to analysts' expectations of $5.23 million. View CAS Medical Systems' Earnings History.

What is the consensus analysts' recommendation for CAS Medical Systems?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CAS Medical Systems in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CAS Medical Systems.

Has CAS Medical Systems been receiving favorable news coverage?

News headlines about CASM stock have been trending somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CAS Medical Systems earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave news articles about the medical technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for CAS Medical Systems.

Who are some of CAS Medical Systems' key competitors?

What other stocks do shareholders of CAS Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CAS Medical Systems investors own include Wells Fargo & Co (WFC), VelocityShares 3x Long Natural Gas ETN (UGAZ), Goldcorp (GG), Vereit (VER), Advanced Micro Devices (AMD), Intrexon (XON), AFLAC (AFL), Newmont Goldcorp (NEM), Magal Security Systems (MAGS) and Virtu Financial (VIRT).

Who are CAS Medical Systems' key executives?

CAS Medical Systems' management team includes the folowing people:
  • Mr. Thomas M. Patton, Pres, CEO & Director (Age 55)
  • Mr. Jeffery A. Baird, CFO & Sec. (Age 65)
  • Mr. John K. Gamelin, VP of R&D (Age 54)
  • Dr. Paul B. Benni, Chief Scientific Officer (Age 51)
  • Susan Carron, Director of Corp. Communications

Who are CAS Medical Systems' major shareholders?

CAS Medical Systems' stock is owned by a number of of retail and institutional investors. Top institutional investors include Ingalls & Snyder LLC (1.00%), Harvest Management LLC (0.11%), GABELLI & Co INVESTMENT ADVISERS INC. (0.09%), Virtu Financial LLC (0.06%) and Penbrook Management LLC (0.04%). View Institutional Ownership Trends for CAS Medical Systems.

Which institutional investors are selling CAS Medical Systems stock?

CASM stock was sold by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC and Penbrook Management LLC. View Insider Buying and Selling for CAS Medical Systems.

Which institutional investors are buying CAS Medical Systems stock?

CASM stock was purchased by a variety of institutional investors in the last quarter, including Harvest Management LLC, GABELLI & Co INVESTMENT ADVISERS INC. and Virtu Financial LLC. View Insider Buying and Selling for CAS Medical Systems.

How do I buy shares of CAS Medical Systems?

Shares of CASM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CAS Medical Systems' stock price today?

One share of CASM stock can currently be purchased for approximately $2.45.

How big of a company is CAS Medical Systems?

CAS Medical Systems has a market capitalization of $71.88 million and generates $21.92 million in revenue each year. The medical technology company earns $-5,960,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. CAS Medical Systems employs 76 workers across the globe.View Additional Information About CAS Medical Systems.

What is CAS Medical Systems' official website?

The official website for CAS Medical Systems is

How can I contact CAS Medical Systems?

CAS Medical Systems' mailing address is 44 East Industrial Road, Branford CT, 06405. The medical technology company can be reached via phone at 203-488-6056 or via email at [email protected]

MarketBeat Community Rating for CAS Medical Systems (NASDAQ CASM)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  261
MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe CASM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CASM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/16/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel